TOTAL MAGNESIUM CONCENTRATIONS IN SERUM AND ERYTHROCYTES BEFORE AND AFTER TREATMENT WITH MAGNESIUM L-ASPARTATE HYDROCHLORIDE - REFERENCE TOCLINICAL SYNDROMES

461 patients with various symptoms supposed to be due to magnesium def iciency were treated with daily dosis of 15 mmol magnesium L-aspartate hydrochloride trihydrate * over a mean period of 8.5 weeks. The int ensity of their symptoms was graded and total magnesium levels in seru m and red blood cells were measured (AAS technique, one single laborat ory) before and after treatment. For each group of clinical symptoms s tudied some reduction in intensity after treatment could be observed. On the other hand concentrations of magnesium in serum and erythrocyte s showed only slight changes during therapy. A more detailed analysis looking at the relation between clinical symptoms and magnesium levels revealed a rather poor correlation.